State of Health Tech Space and Recent M&A Activity

This chapter discusses the state of the health tech space, including the excitement around AI and GLP1, and the recent M&A and partnership announcements in the pharma and AI sectors. The speaker reflects on the outlook for IPOs in 2024 and the role of M&A in shaping the market. They also explore Lux Capital's investments in deep tech and science-focused areas, particularly in healthcare and biotech pharma.